Health TrialsbyHealthPanel

Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Control of Myopia in Young Children Using H.O.P.E. Lenses Combined With 0.02% Atropine Eye Drops

A multicenter, prospective, intervention study on the control of myopia in young children using high-order phase element array microstructure lenses (H.O.P.E.) in combination with low-concentration atropine eye drops (0.02%)

Participants needed: 264
Trial details
Age: 6-9Biological sex: AllType: InterventionalSponsor: Ruihua WeiUpdated: Sep 29, 2026Locations: 1
Eligibility criteria

Age: 6-9 years old (6 years old but under 10 years old), gender not restricted; [+3]

Those who have discontinued the use of atropine eye drops (due to glaucoma or a... [+8]

Read more
Status: Not yet recruiting

Therapeutic Efficacy of Different Repeated Low-Intensity Red Light Devices and Different Usage Frequencies

To explore the effectiveness and safety of repeated exposure to repeated low-intensity red light

Participants needed: 30
Trial details
Age: 18-35Biological sex: AllType: InterventionalSponsor: Ruihua WeiUpdated: Sep 22, 2025Locations: 1
Eligibility criteria

18-35 years old, gender not limited; Obtained informed consent.

Obvious strabismus and amblyopia [+10]

Read more
Status: Recruiting

Repeatability of AO-SLO (Mona IIa) Technology and Cone Cell Density of Individuals Use Repeated Low-level Red-light Therapy

To explore the repeatability of AO-SLO (Mona IIa) technology and the difference of cone cell density between individuals who used or not used repeated low-intensity red light treatment

Participants needed: 180
Trial details
Age: 6-55Biological sex: AllType: InterventionalSponsor: Ruihua WeiUpdated: Sep 15, 2025Locations: 1
Eligibility criteria

6 - 55 years old, gender not limited; Obtained informed consent.

Children with obvious strabismus and amblyopia [+10]

Read more
Status: Recruiting

Atropine (0.02%, 0.04%) Combined With Defocus DIMS for Moderate and High Myopia Control

To evaluate the effectiveness and safety of DIMS, low concentration atropine eye drops,and atropine combined with DIMS in controlling axial length and refraction in children with moderate to high myopia.

Participants needed: 410
Trial details
Phase: Phase 1, Phase 2Age: 6-12Biological sex: AllType: InterventionalSponsor: Ruihua WeiUpdated: Sep 8, 2025Locations: 1
Eligibility criteria

School-age children aged 6 to 12 years (including boundary value) [+4]

Used or currently using orthokeratology, multifocal contact lenses, defocusing f... [+11]

Read more